Listen to physicians talk about their NeuroStar TMS Therapy® experiences in helping patients who have not benefited from antidepressant medication.

Testimonials do not necessarily represent expected patient results as determined from NeuroStar clinical trials. Before reviewing, please note the FDA-cleared indication for use and clinical trials data for NeuroStar TMS Therapy.

In an NIMH-funded, independent, randomized controlled trial, patients treated with TMS using the NeuroStar TMS System, were four times more likely to achieve remission compared to patients receiving sham treatment (P = 0.0173; odds ratio = 4.05).6

Peer Reference NeuroStar sites

NeuroStar’s extensive network of Service and Support Experts